Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
This study has been completed.
Sponsor:
Novavax
Collaborator:
Instituto Mexicano del Seguro Social
Information provided by (Responsible Party):
Novavax
ClinicalTrials.gov Identifier:
NCT01072799
First received: February 19, 2010
Last updated: April 23, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |